Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Hsu AY, Kuo HT, Wang YH, et al
Maintenance uses 1-2mg weekly thereafter
Retatrutide: Phase-2 trial Retatrutide is an investigational triple agonist (GLP-1, GIP and glucagon receptors), adding a third hormone target to potentially boost metabolism further
This mechanism is the focus of most current research interest, particularly in studies on stubborn visceral fat and metabolic regulation
It originated with psychedelics such as LSD or psilocybin but has expanded to medications such as semaglutide for weight management
US$ 29.15
US$ 27.06
US$ 21.43
